Publications by authors named "Nicholas Rossiter"

Claim this Profile
I
Iron addicted colorectal cancers exploit Heme-Complex II axis to resist oxidative cell death.
Chesta Jain, Muqit Essani, Roshan Kumar, Nupur K Das, Rashi Singhal, Nicholas J Rossiter

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.
Stephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, Myungsun Shin, Sumeet Solanki, Nicholas J Rossiter

Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.
Caleb Cheng, Jing Hu, Rahul Mannan, Tongchen He, Rupam Bhattacharyya, Nicholas J Rossiter

Nature· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Hands-On Introduction to Data Analytics for Biomedical Research.
Joshua Pickard, Victoria E Sturgess, Katherine O McDonald, Nicholas Rossiter, Kelly B Arnold

Function (Oxf)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD4-mediated epigenetic regulation of endoplasmic reticulum-mitochondria contact sites is governed by the mitochondrial complex III.
Brandon Chen, Drew C Stark, Pankaj V Jadhav, Theophilus M Lynn-Nguyen, Benjamin S Halligan, Nicholas J Rossiter

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions.
Kyle M Flickinger, Kelli M Wilson, Nicholas J Rossiter, Andrea L Hunger, Paresh V Vishwasrao

Sci Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer.
Stephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, Myungsun Shin, Sumeet Solanki, Nicholas J Rossiter

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer.
Caleb Cheng, Jing Hu, Rahul Mannan, Rupam Bhattacharyya, Nicholas J Rossiter

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions.
Kyle M Flickinger, Kelli M Wilson, Nicholas J Rossiter, Andrea L Hunger, Tobie D Lee

bioRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9 Screening to Identify Conditionally Essential Genes in Human Cell Lines.
Kimberly S Huggler, Nicholas J Rossiter, Kyle M Flickinger, Jason R Cantor

Methods Mol Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR screens in physiologic medium reveal conditionally essential genes in human cells.
Nicholas J Rossiter, Kimberly S Huggler, Charles H Adelmann, Heather R Keys, Ross W Soens

Cell Metab· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis